Mifepristone modulates serotonin transporter function
Regulating serotonin expression can be used to treat psychotic depression. Mifepristone, a glu- cocorticoid receptor antagonist, is an effective candidate for psychotic depression treatment. However, the underlying mechanism related to serotonin transporter expression is poorly un- derstood. In this...
Saved in:
Published in | Neural regeneration research Vol. 9; no. 6; pp. 646 - 652 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
India
Medknow Publications and Media Pvt. Ltd
15.03.2014
Medknow Publications & Media Pvt. Ltd Department of Physiology and Neurobiology, Xinxiang Medical University, Xinxiang, Henan Province, China Medknow Publications & Media Pvt Ltd |
Subjects | |
Online Access | Get full text |
ISSN | 1673-5374 1876-7958 |
DOI | 10.4103/1673-5374.130112 |
Cover
Loading…
Summary: | Regulating serotonin expression can be used to treat psychotic depression. Mifepristone, a glu- cocorticoid receptor antagonist, is an effective candidate for psychotic depression treatment. However, the underlying mechanism related to serotonin transporter expression is poorly un- derstood. In this study, we cloned the human brain serotonin transporter into Xenopus oocytes, to establish an in vitro expression system. Two-electrode voltage clamp recordings were used to detect serotonin transporter activity. Our results show that mifepristone attenuates serotonin transporter activity by directly inhibiting the serotonin transporter, and suggests that the se- rotonin transporter is a pharmacological target of mifepristone for the treatment of psychotic depression. |
---|---|
Bibliography: | nerve regeneration; psychotic depression; mifepristone; serownin transporter; Xenopusoocyte; serotonin; depression; two-electrode voltage clamp; current recording; antidepressants; sero-tonin transmission; NSFC grant; neural regeneration Regulating serotonin expression can be used to treat psychotic depression. Mifepristone, a glu- cocorticoid receptor antagonist, is an effective candidate for psychotic depression treatment. However, the underlying mechanism related to serotonin transporter expression is poorly un- derstood. In this study, we cloned the human brain serotonin transporter into Xenopus oocytes, to establish an in vitro expression system. Two-electrode voltage clamp recordings were used to detect serotonin transporter activity. Our results show that mifepristone attenuates serotonin transporter activity by directly inhibiting the serotonin transporter, and suggests that the se- rotonin transporter is a pharmacological target of mifepristone for the treatment of psychotic depression. 11-5422/R ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Author contributions: Li CK designed the study and wrote the manuscript. Shan LL cloned the serotonin transporter. Li XJ and Wei LY performed drug screening using the two-electrode voltage-clamp technique. Li DL designed primers and revised the manuscript. All authors read and approved the final manuscript. Chaokun Li and Linlin Shan contributed equally to this article. |
ISSN: | 1673-5374 1876-7958 |
DOI: | 10.4103/1673-5374.130112 |